CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2004-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1167/IOVS.03-1126PMID 15452087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gateways to clinical trials.

  2005cited by this paper
• Carboxyamido-Triazole Modulates Retinal Pigment Epithelial and Choroidal Endothelial Cell Attachment, Migration, Proliferation, and MMP-2 Secretion of Choroidal Endothelial Cells

  2005cited by this paper
• CAI: effects on cytotoxic therapies in vitro and in vivo

  2004cited by this paper
• 2-Methoxyestradiol: an Endogenous Antiangiogenic and Antiproliferative Drug Candidate

  2004cited by this paper
• Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.

  2003cited by this paper
• Regulation of the pro‐angiogenic microenvironment by carboxyamido‐triazole

  2003cited by this paper
• CAI inhibits the growth of small cell lung cancer cells.

  2003cited by this paper
• ANECORTAVE ACETATE AS MONOTHERAPY FOR THE TREATMENT OF SUBFOVEAL LESIONS IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION (AMD): Interim (Month 6) Analysis of Clinical Safety and Efficacy

  2003cited by this paper
• COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity.

  2003cited by this paper
• Topical nepafenac inhibits ocular neovascularization.

  2003cited by this paper
• Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results.

  2003cited by this paper
• Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor.

  2003cited by this paper
• Pharmacological Strategies to Block Rod Photoreceptor Apoptosis Caused by Calcium Overload: A Mechanistic Target-Site Approach to Neuroprotection

  2003cited by this paper
• Spatial pattern and temporal evolution of retinal oxygenation response in oxygen-induced retinopathy.

  2003cited by this paper
• The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol.

  2003cited by this paper
• Pharmacological strategies to block rod photoreceptor apoptosis caused by calcium overload: A mechanistic target-site approach to neuroprotection.

  2003cited by this paper
• Early detection and treatment of neovascular age-related macular degeneration.

  2002cited by this paper
• Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.

  2002cited by this paper
• Absence of voltage-dependent calcium channels delays photoreceptor degeneration in rd mice.

  2002cited by this paper
• Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides

  2002cited by this paper
• Alpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the rat

  2002cited by this paper
• Inhibition of Angiogenesis: Treatment Options for Patients with Metastatic Prostate Cancer

  2002cited by this paper
• Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.

  2002cited by this paper
• Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.

  2002cited by this paper
• Inducible Nitric Oxide Synthase Mediates Retinal Apoptosis in Ischemic Proliferative Retinopathy

  2002cited by this paper
• Age-Related Macular Degeneration

  2002cited by this paper
• Limited macular translocation: current concepts.

  2002cited by this paper
• Phase I and pharmacokinetic study of a micronized formulation of carboxyamidotriazole, a calcium signal transduction inhibitor: toxicity, bioavailability and the effect of food.

  2002cited by this paper
• [Retinal neuronal cell death: molecular mechanism and neuroprotection].

  2002cited by this paper
• Somatostatin analogs inhibit neonatal retinal neovascularization.

  2002cited by this paper
• Efficacy of Prinomastat® (AG3340), a matrix metalloprotease inhibitor, in treatment of retinal neovascularization

  2002cited by this paper
• [Age-related macular degeneration--new possibilities for prophylactic measures].

  2002cited by this paper
• PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION

  2002influential reference
• Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

  2002cited by this paper
• Gateways to clinical trials.

  2002cited by this paper
• An update on photodynamic therapy in age-related macular degeneration

  2002cited by this paper
• Transscleral diffusion of carboplatin: an in vitro and in vivo study.

  2002cited by this paper
• Macular infarction after transpupillary thermotherapy for subfoveal choroidal neovascularization in age-related macular degeneration.

  2002cited by this paper
• Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1

  2002cited by this paper
• Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization.

  2002cited by this paper
• In Vitro Human Scleral Permeability of Fluorescein, Dexamethasone-Fluorescein, Methotrexate-Fluorescein and Rhodamine 6G and the Use of a Coated Coil as a New Drug Delivery System

  2002cited by this paper
• Angiogenesis and metastasis.

  2002cited by this paper
• Åldersrelaterad makuladegeneration - nya möjligheter för profylax och terapi

  2002cited by this paper
• Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats

  2001cited by this paper
• The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.

  2001cited by this paper
• Captopril improves retinal neovascularization via endothelin-1.

  2001cited by this paper
• Systemically Expressed Soluble Tie2 Inhibits Intraocular Neovascularization

  2001cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

  2001cited by this paper
• A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction.

  2001cited by this paper
• Angiostatin inhibits pathological but not physiological retinal angiogenesis.

  2001cited by this paper
• Adenosine receptor antagonists and retinal neovascularization in vivo.

  2001cited by this paper
• Topical application of integrin antagonists inhibits proliferative retinopathy.

  2001cited by this paper
• Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor

  2001cited by this paper
• Transscleral drug delivery for posterior segment disease.

  2001cited by this paper
• Transpupillary thermotherapy for subfoveal occult choroidal neovascularization: effect on ocular perfusion.

  2001cited by this paper
• [Diabetic retinopathy].

  2001cited by this paper
• Treatment of age-related macular degeneration.

  2000cited by this paper
• Experimental Retinopathy of Prematurity: Angiostatic Inhibition by Nimodipine, Ginkgo-Biloba, and Dipyridamole, and Response to Different Growth Factors

  2000cited by this paper
• Pentoxifylline inhibition of vasculogenesis in the neonatal rat retina.

  2000cited by this paper
• Pharmacokinetics and Safety of an Anti-Vascular Endothelial Growth Factor Aptamer (NX1838) Following Injection into the Vitreous Humor of Rhesus Monkeys

  2000cited by this paper
• Transpupillary thermotherapy for age-related macular degeneration: long-pulse photocoagulation, apoptosis, and heat shock proteins.

  2000cited by this paper
• Drug delivery for posterior segment eye disease.

  2000cited by this paper
• Squalamine improves retinal neovascularization.

  2000cited by this paper
• Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway.

  2000cited by this paper
• Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1.

  2000cited by this paper
• A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer.

  1999cited by this paper
• Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

  1999cited by this paper
• Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration.

  1999cited by this paper
• Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy.

  1999cited by this paper
• Suppression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbamate in mice.

  1999cited by this paper
• Dexamethasone Reduces Oxygen Induced Retinopathy in a Mouse Model

  1999cited by this paper
• Effect of antiangiogenic agents on experimental animal models of hepatocellular carcinoma.

  1999cited by this paper
• Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

  1999cited by this paper
• Calcium Overload Triggers Rod Photoreceptor Apoptotic Cell Death in Chemical‐Induced and Inherited Retinal Degenerations

  1999cited by this paper
• Neuroprotection in relation to retinal ischemia and relevance to glaucoma.

  1999cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

  1999cited by this paper
• The potential of neuroprotection in glaucoma treatment.

  1999cited by this paper
• Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy.

  1999cited by this paper
• High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection.

  1999cited by this paper
• Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes.

  1998cited by this paper
• The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.

  1998cited by this paper
• Photodynamic therapy. Minimally invasive treatment of choroidal neovascularization

  1998cited by this paper
• Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531.

  1998cited by this paper
• Diabetic retinopathy.

  1998cited by this paper
• Müller cell changes in human diabetic retinopathy.

  1998cited by this paper
• [Neuronal cell death mechanism in glaucomatous optic neuropathy].

  1998cited by this paper
• Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.

  1997cited by this paper
• Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.

  1997cited by this paper
• Antiproliferative and antiinvasive effects of carboxyamido-triazole on breast cancer cell lines.

  1997cited by this paper
• The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study.

  1997cited by this paper
• Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations.

  1997cited by this paper
• Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor

  1997cited by this paper
• Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor.

  1997cited by this paper
• Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitor.

  1997cited by this paper
• Growth factors in age-related macular degeneration: pathogenic and therapeutic implications.

  1997cited by this paper
• Diabetic eye disease.

  1997cited by this paper
• Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection.

  1997cited by this paper
• Regulation of cellular tyrosine phosphorylation by stimulatory and inhibitory muscarinic acetylcholine receptors.

  1997cited by this paper
• Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.

  1996cited by this paper
• Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor.

  1996cited by this paper

• Carboxyamidotriazole Complexed to PLGA Is Safe, Effective, and Durable in Models of Neovascular Retinal Disease

  2025cites this paper
• Combinatorial treatment with carboxyamidotriazole- orotate and temozolomide in sc-implanted human LOX IMVI melanoma xenografts

  2012influential citation
• Targeting retinal and choroid neovascularization using the small molecule inhibitor carboxyamidotriazole.

  2010cites this paper
• Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).

  2008cites this paper
• Arachidonic Acid–Induced Ca2+ Entry Is Involved in Early Steps of Tumor Angiogenesis

  2008cites this paper
• Comparative pharmacokinetic profile of carboxyamidotriazole and carboxyamidotriazole- orotate

  2007cites this paper
• Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage.

  2006cites this paper
• EFFECTIVE TRANSSCLERAL DELIVERY OF TWO RETINAL ANTI-ANGIOGENIC MOLECULES: Carboxyamido-triazole (CAI) and 2-Methoxyestradiol (2ME2)

  2005cites this paper
• Carboxyamido-Triazole Modulates Retinal Pigment Epithelial and Choroidal Endothelial Cell Attachment, Migration, Proliferation, and MMP-2 Secretion of Choroidal Endothelial Cells

  2005cites this paper